CerebraMed Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
CerebraMed General Information
Description
Operator of a pharmaceutical company for the treatment of Alzheimer's disease. The company offers a medicinal treatment for patients with Alzheimer's disease to slow down or halt the damage to the brain's nerve cells. The company has developed proprietary GSK-3 inhibitors as drug candidates.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Drug Delivery
Primary Office
- Tel Aviv
- Israel
CerebraMed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 03-Feb-2016 | Completed | Startup |
CerebraMed Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Hagit Eldar-Finkelman Ph.D | Founder |
CerebraMed Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Brainnovations | Accelerator/Incubator | 000 0000 | 000000 0 |